Loarce-Martos, Jesús http://orcid.org/0000-0003-1352-9539
García-Fernández, Antía
López-Gutiérrez, Fernando
García-García, Verónica http://orcid.org/0000-0003-0126-0229
Calvo-Sanz, Laura
del Bosque-Granero, Iván
Terán-Tinedo, M. Andreína
Boteanu, Alina
Bachiller-Corral, Javier http://orcid.org/0000-0001-8954-209X
Vázquez-Díaz, Mónica
Article History
Received: 22 July 2020
Accepted: 31 August 2020
First Online: 18 September 2020
Compliance with ethical standards
:
: Dr. Loarce-Martos reports personal fees from Celgene S.L.U., outside the submitted work; Dr. García-Fernández has nothing to disclose; Dr. López-Gutiérrez has nothing to disclose; Dr. García-García has nothing to disclose; Dr. Calvo-Sanz has nothing to disclose; Dr. del Bosque-Granero has nothing to disclose; Dr. Terán-Tinedo has nothing to disclose; Dr. Boteanu has nothing to disclose; Dr. Bachiller-Corral has nothing to disclose; Dr. Vázquez-Díaz reports personal fees and non-financial support from Sandoz, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Merck Sharp and Dohme, outside the submitted work.
: The current study is a sub-analysis of a larger study focused in SARS-CoV-2 infection in RMD patients (study number: 136/20), and was approved by the local ethics committee of our hospital (comité de ética de la investigación con medicamentos del Hospital Universitario Ramón y Cajal) on 05/05/2020. All patients provided informed consent to participate and for publication prior to their inclusion.
Free to read: This content has been made available to all.